CREATINE KINASE (CK) - ANVISA Registration 80146502099

Access comprehensive regulatory information for CREATINE KINASE (CK) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502099 and manufactured by ABBOTT GMBH. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including GOLD ANALISA DIAGNOSTICA LTDA, KATAL BIOTECNOLOGICA INDÚSTRIA E COMÉRCIO LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80146502099
Registration Details
ANVISA Registration Number: 80146502099
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Alinity c Creatine Kinase
Risk Class II

Registration Details

80146502099

25351713062201782

56998701000116

Company Information

ABBOTT GMBH
Germany
PT: ALEMANHA

Dates and Status

Apr 02, 2018

VIGENTE

09/18/2025 19:00:01